• Open Access

Venice Chart International Consensus Document on Atrial Fibrillation Ablation: 2011 Update

Authors


  • J Cardiovasc Electrophysiol, Vol. 23, pp. 890-923, August 2012

  • Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms

  • For the Venice Chart composition (Committees, members, affiliation) see Appendix.

  • This document was made possible by an educational grant from Biosense Webster, a Johnson & Johnson Company.

  • Dr. Raviele received speaker's bureau compensation from Biosense Webster and St. Jude Medical and is a consultant to Sanofi and Boehringer Ingelheim. Dr. Natale received speaker's bureau compensation from Boston Scientific, Biosense Webster, Biotronik, Medtronic, and St. Jude Medical, and is a consultant to Biosense Webster, Endosense, Life Watch, and St. Jude Medical. At the time of this document preparation, Dr. Calkins received honoraria from Biosense Webster, and Sanofi-aventis; was on the scientific advisory boards of Atricure, Medtronic, and Biosense Webster; owned stock in VytronUS and iRhythm. Dr. Camm participated on research grants from Daiichi-Sankyo, Pfizer, and Sanofi-aventis; received speaker's bureau compensation from Sanofi-aventis, Boehringer Ingelheim, Merck, and Bayer; received honoraria from Medtronic, and Boston Scientific; is a consultant to Boehringer Ingelheim. Dr. Connolly participated on research grants from Boehringer Ingelheim, BMS, Bayer, and Portola; received honoraria from Boehringer Ingelheim, BMS, Bayer, and Pfizer; is a consultant to Boehringer Ingelheim, BMS, and Pfizer. Dr. Damiano participated on a research grant from Atricure; received honoraria from Medtronic and support for travel or lectures from Estech; is a consultant to Atricure, and Medtronic. Dr. De Ponti received speaker's bureau compensation from Biosense Webster. Dr. Edgerton received speaker's bureau compensation from Atricure, and Medtronic. Dr. Haissaguerre received research support from Biosense Webster, Phillips, Stereotaxis, CardioInsight, Bard, and Medtronic, and is a consultant to Biosense Webster, and CardioInsight. Dr. Jalife reports participation on a Gilead Research Grant, and stock options in Topera, Inc. Dr. Kirchhof reports participation on research grants from Medtronic, 3M Medica, Cardiovascular Therapeutics, Medtronic, Omron, Sanofi, St. Jude Medical, and consulting fees and honoraria from 3M Medica, Bayer, Boehringer Ingelheim, Daiichi-Sankyo, Medtronic, Merck, MSD, Otsuka Pharma, Pfizer/BMS, Sanofi, Servier, Siemens, and Takeda. Dr. Kottkamp is a consultant to Biosense Webster, and St. Jude Medical. Dr. Marchlinski received honoraria from Sanofi-aventis, and Biosense Webster, and is a consultant to Medtronic, and Biosense Webster. Dr. Packer receives research funding from Biosense Webster, Boston Scientific/EPT, Endosense, EpiEP, EP Advocate, Medtronic CryoCath LP, St. Jude Medical, Siemens, AcuNav, and Thermedical (EP Limited); in the last 12 months he has provided consulting services for Biosense Webster, CardioFocus, Cardiomedics, Cyberheart, Endosense, Johnson & Johnson Healthcare Systems, Medtronic CryoCath, OrthoMcNeill, Sanofi-aventis, Siemens, St. Jude Medical, Siemens AG, and Valencia Technologies, but he received no personal compensation for these consulting activities. Dr. Packer received royalties from St. Jude Medical. Dr. Prystowsky is the Editor-in-Chief of JCE; participated on the CABANA trial; is on the board of directors and holds stock options in Stereotaxis, and Cardionet, as well as stock options in Topera, Inc; serves as a consultant to Bard and Medtronic for educational programs. Dr. Reddy participated on research grants supported by St. Jude Medical, Biosense Webster, and Endosense, Medtronic, Medtronic CryoCath, CardioFocus, Atritech, Phillips, Voyage, and Sentre Heart; he has received honoraria and is a consultant to unspecified companies. Dr. Themistoclakis participated on research grants from St. Jude Medical, and Biosense Webster, and received speaker's bureau compensation from Biosense Webster, St. Jude Medical, and Sanofi-aventis. Dr. Wilber participated on a research grant from Biosense Webster; received honoraria from Biosense Webster, Medtronic, and St. Jude Medical; is a consultant to Medtronic, Biosense Webster, and St. Jude Medical. Dr. Willems participated on a research grant from St. Jude Medical; received speaker's bureau compensation from St. Jude Medical, and Boston Scientific; is a consultant to St. Jude Medical, and Boehringer Ingelheim. Other authors: No disclosures.

Antonio Raviele, M.D., Cardiovascular Department, Arrhythmia Center and Center for Atrial Fibrillation, Dell’Angelo Hospital, Venice-Mestre, Italy. Fax: +39 041 965 7235; E-mail: araviele@tin.it

Ancillary